OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases

por Thiele, Michael, Donnelly, Seamas C, Mitchell, Robert A
Publicado 2022

Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic

por Rossmueller, Gregor, Mirkina, Irina, Maurer, Barbara, Hoeld, Verena, Mayer, Julia, Thiele, Michael, Kerschbaumer, Randolf J., Schinagl, Alexander
Publicado 2023

Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer

por Schinagl, Alexander, Thiele, Michael, Douillard, Patrice, Völkel, Dirk, Kenner, Lukas, Kazemi, Zahra, Freissmuth, Michael, Scheiflinger, Friedrich, Kerschbaumer, Randolf J.
Publicado 2016

Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics

por Douillard, Patrice, Freissmuth, Michael, Antoine, Gerhard, Thiele, Michael, Fleischanderl, Daniel, Matthiessen, Peter, Voelkel, Dirk, Kerschbaumer, Randolf J., Scheiflinger, Friedrich, Sabarth, Nicolas
Publicado 2019

CHO starter cell lines for manufacturing of proteins with pre-defined glycoprofiles

por Winkler, Karsten, Thiele, Michael, Berthold, Rita, Kirschenbaum, Nicole, Sczepanski, Marco, Horsten, Henning von, Seitz, Susanne, Arnold, Norbert, Scheidig, Axel J, Sandig, Volker
Publicado 2013